Supernus Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.10.24	Supernus Announces Promising Data From Phase 2a Study Of SPN-820 In Major Depressive Disorder (RTTNews)
19.08.24	FDA To Review Supernus Pharma' NDA For SPN-830 Apomorphine Infusion Device (RTTNews)
07.05.24	Supernus's ADHD Drug Qelbree To Be Commercialized In Latin America By M8 Pharma (RTTNews)
28.03.24	Biotech Stocks Facing FDA Decision In April 2024 (RTTNews)
05.02.24	Supernus Pharma Wins Infringement, Validity Case On Trokendi XR Against Torrent (RTTNews)
19.01.23	12 Biotech Stocks Hit New Highs; Did You Make The Most Of It? (RTTNews)
10.10.22	FDA Declines To Approve Supernus Pharma's Parkinson's Drug (RTTNews)
30.09.22	Biotech Stocks Facing FDA Decision In October 2022 (RTTNews)
02.05.22	FDA Approves Supernus Pharmaceuticals' Qelbree For Treatment Of ADHD In Adults (RTTNews)
02.05.22	Supernus Pharma: FDA Approves Expanded Indication For Qelbree - Quick Facts (RTTNews)
02.05.22	Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults (PR Newswire)
28.03.22	Biotech Stocks Facing FDA Decision In April 2022 (RTTNews)
11.10.21	Supernus Pharma To Acquire Adamas Pharma For Total Consideration Up To $9.10/shr (RTTNews)
03.04.21	FDA Approves Supernus's Qelbree For Treatment Of Attention-deficit Hyperactivity Disorder (RTTNews)
27.03.21	Biotech Stocks Facing FDA Decision In April 2021 (RTTNews)
23.12.20	Stock Alert: Supernus Pharmaceuticals Up 14% On Positive Trial Results Of ADHD Drug (RTTNews)
23.12.20	CYCC Gets $7Mln Strategic Investment, SUPN Abuzz, SNGX Plunges On Oral Mucositis Trial Data (RTTNews)
10.11.20	Pre-market Movers In Healthcare Sector: ALT, AFMD, BNTX, PFE, AZN, SUPN… (RTTNews)
10.11.20	ARNA Falls Short Of ADVICE, PFE's COVID-19 Vaccine Shows 90% Efficacy, SUPN Hit By Double Whammy (RTTNews)
08.11.20	Week Ahead In Pharma: FDA Decisions, SITC Presentations, 13D SEC Filing (RTTNews)
04.11.20	Stock Alert: Supernus Pharmaceuticals Jumps 22% On Quarterly Results, Sales View (RTTNews)
04.11.20	Pre-market Movers In Healthcare Sector: DRAD, SUPN, ARGX, AZN, APVO… (RTTNews)
01.11.20	Week Ahead In Pharma: COVID-19 Data Readout, FDA Decisions, CTAD Presentation (RTTNews)
26.10.20	Biotech Stocks Facing FDA Decision In November 2020 (RTTNews)
19.08.20	ALBO Drops NASH Drug Development, FDA Says No To Filgotinib, SUPN On Watch, Vanda & ODYSSEY (RTTNews)
26.02.20	IOVA Abuzz, SUPN Study Flops, IMV Plunges Despite Positive Ovarian Cancer Data (RTTNews)
06.11.19	NXTC Catapults To New High, SUPN Fails Phase 3 Trial, PTLA Delivers Strong Q3 (RTTNews)
29.03.19	ARDS On The Move, GLPG Reports Positive Data, PRTO Plunges On PATENCY-2 Results (RTTNews)
28.03.19	Supernus Pharma Needs Your Attention... (RTTNews)
06.12.18	Supernus Pharma To Report Phase III SPN-812 Data - Your Attention, Please (RTTNews)
26.11.18	Biotech Stocks Facing FDA Decision In December (RTTNews)
01.06.18	Faruqi & Faruqi, LLP is Investigating Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of its Shareholders (PR Newswire)
09.05.18	AKCA Faces FDA Panel Tomorrow, ALDR To Report Data In June, TCMD Riding High (RTTNews)
18.01.18	JUNO Flies On Takeover Rumor, PRTO For Long Haul, SUPN Gaining Strength (RTTNews)
22.09.17	IPXL Mulls Merger, QURE Attracts Attention, No Let Up In ICPT Ocaliva Concerns (RTTNews)
20.09.17	CAPR Is Hot, VBLT In Rally Mode, MYOK's Data Heartening, MediWound Bleeds (RTTNews)
05.09.17	Technical Snapshots for These Generic Drugs Stocks -- Catalyst Pharma, Flexion Therapeutics, Supernus Pharma, and Lannett (PR Newswire)
16.08.17	ALXN's Strengthening Patents, FOLD's Fabry Drug Approved In OZ, VBIV Surges (RTTNews)
31.07.17	How These Generic Drugs Stocks are Performing? -- Akari Therapeutics, Flexion Therapeutics, Lannett, and Supernus Pharma (PR Newswire)
18.07.17	Gainers & Losers Of July 17: ACRX, QDEL, AKCA, SGMO, SUPN... (RTTNews)
12.06.17	Generic Drugs Stock Performance Review -- Ironwood Pharma, Medicines Co., Supernus Pharma, and Pacira Pharma (PR Newswire)
01.06.17	Gainers & Losers Of May 31: NDRM, CBIO, SUPN, MACK, VSTM... (RTTNews)
10.05.17	ARRY Hits Trial Goals, DEPO Falls On Q1 Results, SAGE Awaits Data In Q3 (RTTNews)
01.05.17	How These Generic Drugs Stocks are Faring? -- Medicines Co., Ironwood Pharma, Pacira Pharma, and Supernus Pharma (PR Newswire)
06.04.17	ARLZ Hands Out Pink Slips, JAZZ On A High Note, STDY On Track, TENX Abuzz (RTTNews)
03.04.17	New 52-week Highs On Nasdaq (RTTNews)
28.03.17	Research Reports Initiation on Generic Drugs Stocks -- Medicines, Ironwood Pharma, Pacira Pharma, and Supernus Pharma (PR Newswire)
08.03.17	AXSM Looks To Busy Year Ahead, SUPN Makes Peace Again, ESPR Hits New High (RTTNews)
07.03.17	NOVN Moves Ahead, PTCT Finally Achieves It, TGTX Gets GENUINE Reaction (RTTNews)
16.02.17	How These Healthcare Stocks are Faring? -- GlaxoSmithKline, Shire, Pacira Pharma, and Supernus Pharma (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Roche Hldg G	263.50	2.33 %	K V
Logitech Intl	79.34	2.01 %	K V
Lonza Grp	550.20	1.55 %	K V
Nestle	75.06	1.41 %	K V
Swiss Re	134.30	1.28 %	K V
Geberit	511.40	-0.78 %	K V
Kuehne+Nagel Int	207.40	-0.96 %	K V
Sika	215.50	-1.01 %	K V
Holcim	87.48	-1.13 %	K V
ABB	48.95	-1.33 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Supernus Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten